GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

65 hedge funds and large institutions have $37.3M invested in Galectin Therapeutics in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
15
Reduced
14
Closed
12
Calls
$2.04M
Puts
$2.71M
Net Calls
-$672K
Net Calls Change
+$142K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.86M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$2.27M
3
CS
3
Credit Suisse
Switzerland
$1.03M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$964K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.22M

Top Sellers

1
Bank of Montreal
1
Bank of Montreal
Ontario, Canada
$524K
2
MIM
2
Monashee Investment Management
Massachusetts
$0
3
Barclays
3
Barclays
United Kingdom
$677K
4
OAM
4
Oxford Asset Management
United Kingdom
$0
5
Wolverine Trading
5
Wolverine Trading
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RFM
76
Royal Fund Management
Florida
$0 7 – –
OIA
77
Optimum Investment Advisors
Illinois
$0 20 – –
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4